TY - JOUR
T1 - Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections
AU - Kaul, Rupert
AU - Nagelkerke, Nico J.
AU - Kimani, Joshua
AU - Ngugi, Elizabeth
AU - Bwayo, Job J.
AU - MacDonald, Kelly S.
AU - Rebbaprgada, Anu
AU - Fonck, Karolien
AU - Temmerman, Marleen
AU - Ronald, Allan R.
AU - Moses, Stephen
AU - Bossen, Bolette
AU - Kamunyo, Grace
AU - Wanguru, Ruth
AU - Mwakisha, Rachel
AU - Waithira, Grace
AU - Nganga, Daniel
AU - Nyambogo, Cornelius
AU - Ombette, John
AU - Njeri, Jane
AU - Onyango, Isaiah
AU - Li, Bing
AU - Malonza, Isaac
AU - Maclean, Ian
AU - Mwangi, Francis
AU - Saskin, Refik
AU - Strauss, Judy
AU - Kariuki, Samuel
N1 - Funding Information:
Received 7 February 2007; accepted 19 April 2007; electronically published 25 October 2007. Financial support: Rockefeller Foundation (to S.M.; 2000 HE 025); the European Commission (to M.T.; DG VIII/8, Contract No. 7-RPR-28); the Canadian Research Chair Programme (to R.K.); Ontario HIV Treatment Network (to K.M., Career Scientist); and the Canadian Institutes of Health Research (to R.K., research grant; to S.M., Investigator Award). a Deceased. b Members of the Kibera HIV Study Group listed at end of article. Reprints or correspondence: Dr. Rupert Kaul, Clinical Science Division, University of Toronto, Medical Sciences Building #6356, Toronto, Ontario, Canada, M5S 1A8 ([email protected]).
PY - 2007/12/1
Y1 - 2007/12/1
N2 - Background. Prevalent herpes simplex virus type 2 (HSV-2) infection increases human immunodeficiency virus acquisition. We hypothesized that HSV-2 infection might also predispose individuals to acquire other common sexually transmitted infections (STIs). Methods. We studied the association between prevalent HSV-2 infection and STI incidence in a prospective, randomized trial of periodic STI therapy among Kenyan female sex workers. Participants were screened monthly for infection with Neisseria gonorrhoeae and Chlamydia trachomatis, and at least every 6 months for bacterial vaginosis (BV) and infection with Treponema pallidum, Trichomonas vaginalis, and/or HSV-2. Results. Increased prevalence of HSV-2 infection and increased prevalence of BV were each associated with the other; the direction of causality could not be determined. After stratifying for sexual risk-taking, BV status, and antibiotic use, prevalent HSV-2 infection remained associated with an increased incidence of infection with N. gonorrhoeae (incidence rate ratio [IRR], 4.3 [95% confidence interval {CI}, 1.5-12.2]), T. vaginalis (IRR, 2.3 [95% CI, 1.3-4.2]), and syphilis (IRR, 4.7 [95% CI, 1.1-19.9]). BV was associated with increased rates of infection with C. trachomatis (IRR, 2.1 [95% CI, 1.1-3.8]) and T. vaginalis (IRR, 8.0 [95% CI, 3.2-19.8]). Conclusion. Increased prevalences of HSV-2 infection and BV were associated with each other and also associated with enhanced susceptibility to an overlapping spectrum of other STIs. Demonstration of causality will require clinical trials that suppress HSV-2 infection, BV, or both.
AB - Background. Prevalent herpes simplex virus type 2 (HSV-2) infection increases human immunodeficiency virus acquisition. We hypothesized that HSV-2 infection might also predispose individuals to acquire other common sexually transmitted infections (STIs). Methods. We studied the association between prevalent HSV-2 infection and STI incidence in a prospective, randomized trial of periodic STI therapy among Kenyan female sex workers. Participants were screened monthly for infection with Neisseria gonorrhoeae and Chlamydia trachomatis, and at least every 6 months for bacterial vaginosis (BV) and infection with Treponema pallidum, Trichomonas vaginalis, and/or HSV-2. Results. Increased prevalence of HSV-2 infection and increased prevalence of BV were each associated with the other; the direction of causality could not be determined. After stratifying for sexual risk-taking, BV status, and antibiotic use, prevalent HSV-2 infection remained associated with an increased incidence of infection with N. gonorrhoeae (incidence rate ratio [IRR], 4.3 [95% confidence interval {CI}, 1.5-12.2]), T. vaginalis (IRR, 2.3 [95% CI, 1.3-4.2]), and syphilis (IRR, 4.7 [95% CI, 1.1-19.9]). BV was associated with increased rates of infection with C. trachomatis (IRR, 2.1 [95% CI, 1.1-3.8]) and T. vaginalis (IRR, 8.0 [95% CI, 3.2-19.8]). Conclusion. Increased prevalences of HSV-2 infection and BV were associated with each other and also associated with enhanced susceptibility to an overlapping spectrum of other STIs. Demonstration of causality will require clinical trials that suppress HSV-2 infection, BV, or both.
UR - http://www.scopus.com/inward/record.url?scp=38449118740&partnerID=8YFLogxK
U2 - 10.1086/522006
DO - 10.1086/522006
M3 - Article
C2 - 18008255
AN - SCOPUS:38449118740
SN - 0022-1899
VL - 196
SP - 1692
EP - 1697
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 11
ER -